Streetbeat News

Products Services

ARTL

Artelo Biosciences has reported new data on the development of a solid dosage form of ART12.11 at the CT-CANN24 conference.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:31 pm

CDNA

NTRA

CareDx has responded to Natera's motion for an injunction related to patent 11,111,544, stating that it no longer uses the process in question and believes the motion is irrelevant. CareDx asserts that the injunction will not impact its business or patient access to its products.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:31 pm

STXS

Stereotaxis announced that Penn Presbyterian Medical Center has successfully treated its first heart rhythm patients using the Genesis Robotic Magnetic Navigation System.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:30 pm

BHVN

Biohaven has announced the dosing of the first patient in its Phase 1/2 study of BHV-1510, a Trop-2 directed antibody drug conjugate. This marks a significant milestone in the development of this potential cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:27 pm

INDP

Indaptus Therapeutics (NASDAQ: INDP) presented new cohort data from its Phase 1 clinical trial of Decoy20 at the ASCO Annual Meeting, confirming the original 'Pulse-Prime' hypothesis.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:27 pm

ICE

The New York Stock Exchange (NYSE), part of Intercontinental Exchange, Inc. (NYSE:ICE), is collaborating with CoinDesk Indices to launch cash-settled index options tracking the CoinDesk Bitcoin Price Index (XBX). These contracts are subject to regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:21 pm

AMZN

SAP

AWS and SAP have announced an expanded strategic collaboration to enhance cloud enterprise resource planning (ERP) experiences using generative AI. This partnership aims to integrate SAP AI Core with Amazon Bedrock to provide AI-driven insights and streamline processes for enterprise customers.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:20 pm

BNTX

BioNTech and CEPI are expanding their partnership to enhance Africa's mRNA vaccine ecosystem. CEPI will fund up to $145 million to support BioNTech in broadening the scope of the manufacturing facility in Kigali, Rwanda. The partnership aims to develop local R&D, clinical, and commercial-scale manufacturing capacities for mRNA vaccines in Africa, ensuring equitable access and affordable pricing for low- and middle-income countries.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:15 pm

NIO

TSLA

China is set to allocate over $830 million to advance solid-state battery technology, benefiting key suppliers like Tesla's CATL and Nio-backed WeLion. This investment aims to enhance safety, lifespan, and charging speed of batteries, potentially unlocking a multi-trillion yuan market.

Portfolio Pulse from Anan Ashraf

May 29, 2024 | 12:15 pm

VVPR

VivoPower's Tembo has launched a fully electric pickup utility vehicle, securing initial B2B orders for EU-certified OEM vehicles. The vehicles are on track for full homologation by July 2024. This strategic development allows Tembo to bypass capex intensive assembly processes and fast track to profitable revenues. The OEM program is expected to expand Tembo's total addressable B2B market by over 100% to $203 billion.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:14 pm